Ctrl
K
AALL1331 (intermediate- and high-risk relapse)
Study
AALL1331 (low-risk relapse)
AALL1731
Acid phosphatase, increased
Finding
ACOSOG Z0011 (10-year survival)
ACOSOG Z0011 (5-year survival)
Actinic keratosis
Disease
Acute lymphoblastic leukemia
Acute myeloid leukemia
Acute promyelocytic leukemia
ADAURA
ADIGE
Adjuvant HAIC with FOLFOX for HCC
Adrenal incidentaloma
Adrenocortical carcinoma
ADRIATIC
AEGEAN
Age Trial
AHA STEROID
Aldolase, increased
Alemtuzumab
Drug
ALEX
ALEXANDRA/IMpassion030
ALLEGRO
Alliance A011502
Allopurinol
Alpha-fetoprotein, increased
AMBASSADOR
AMPLIFY (acalabrutinib/venetoclax)
AMPLIFY (acalabrutinib/venetoclax/obinutuzumab)
Ampullary cancer
ANAHYDRET
Anal cancer
Anastrozole
ANCHOR
ANTICIPUSC
Antimicrobial prophylaxis in pancreatoduodenectomy
Anxiety and depression in patients with cancer
API-CAT
Appendiceal neoplasm
AQCS-Assisted Colonoscopy
AQUILA
ARASENS
ARCADIA (post-hoc analysis)
ARES (aspirin BID vs. aspirin OD)
ARES (aspirin TID vs. aspirin OD)
ASC4FIRST
ASCEMBL
Astrocytoma and oligodendroglioma
Atezolizumab
Atezolizumab / hyaluronidase
ATLAS (tamoxifen)
Atrophic gastritis
ATTR-ACT
ATTRibute-CM
Autoimmune hemolytic anemia
AVERT (subgroup analysis)
Axillary lymphadenopathy
AZA-001